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A group of genes that are highly and specifically
expressed in proliferating skeletal myoblasts during
myogenesis was identified. Expression of one
of these genes, Hmga2, increases coincident with
satellite cell activation, and later its expression sig-
nificantly declines correlating with fusion of myo-
blasts into myotubes. Hmga2 knockout mice exhibit
impaired muscle development and reduced myo-
blast proliferation, while overexpression of HMGA2
promotes myoblast growth. This perturbation in
proliferation can be explained by the finding that
HMGA2 directly regulates the RNA-binding protein
IGF2BP2. Add-back of IGF2BP2 rescues the pheno-
type. IGF2BP2 in turn binds to and controls the
translation of a set of mRNAs, including c-myc,
Sp1, and Igf1r. These data demonstrate that the
HMGA2-IGF2BP2 axis functions as a key regulator
of satellite cell activation and therefore skeletal
muscle development.
INTRODUCTION
Myogenesis, which occurs during both postnatal growth and the
regeneration of skeletal muscle after an injury, is a highly ordered
process that can be subdivided into multiple steps. These steps
include the activation of muscle stem cells, differentiation of
these stem cells into committed myoblasts, followed by pro-
liferation and then differentiation of myoblasts, resulting in cell
fusion—to form multinucleated myotubes (Le Grand and
Rudnicki, 2007). Sequential activation of the muscle-specific
transcriptional factors including Pax3, Pax7, Myf5, MyoD,
Myogenin, and Myf6 plays a crucial role in regulating myogene-
sis (Le Grand and Rudnicki, 2007). However, the precise mech-
anism controlling temporal regulation of myogenesis remains
largely unknown.1176 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012HMGA2 is a transcriptional coregulator belonging to a family of
small high-mobility-group (HMG) proteins containing AT-hook
DNA binding domains. HMGA proteins may modulate gene
expression by altering chromatin architecture and/or by re-
cruiting other proteins to the transcription regulatory complex
(Pfannkuche et al., 2009). HMGA2 is highly expressed in various
undifferentiated tissues during embryonic development but is
turned off in most adult tissues (Ashar et al., 2010; Pfannkuche
et al., 2009). Furthermore, HMGA2 is frequently found to be
upregulated in tumor samples, implying that it may play a role
in controlling cell proliferation (Fedele and Fusco, 2010;
Li et al., 2011; Watanabe et al., 2009).
Recent studies have suggested that HMGA2 is expressed and
may play a role in maintaining certain adult stem/progenitor
cells, including, for example, the maintenance of neural stem/
progenitor cells (Nishino et al., 2008). It has recently been re-
ported that HMGA2 is indispensable for the self-renewal of
young but not old neural stem cells, partially through regulating
p16Ink4A (Nishino et al., 2008). However, the regulation of
HMGA2 on p16 Ink4A appears to be indirect, and other critical
downstream effectors of HMGA2 remain to be determined.
Studies of HMGA2 in myogenesis have been inconclusive.
Previous work in tissue culture systems suggested that overex-
pression of HMGA2 in embryonic stem (ES) cells could enhance
myogenesis and myosin heavy chain (MHC) expression (Caron
et al., 2005). But it is unclear whether HMGA2 does so simply
by promoting the differentiation of ES cells toward a myogenic
lineage or whether HMGA2 directly promotes the terminal differ-
entiation of myoblasts.
IGF2BP2 is amember of the IGF2mRNA-binding protein (IMP)
family, which includes IGF2BP1-3. IGF2BP2 contains four KH
domains and two RRM domains and can bind to various RNAs
(Christiansen et al., 2009). IGF2BP2 was shown to bind to Igf2
mRNA and enhances IGF2 translation (Dai et al., 2011). Whether
IGF2BP2 also regulates the translation of other mRNAs is
unknown. HMGA2 could regulate the transcription of Igf2bp2
during embryonic development (Cleynen et al., 2007), but
the biological significance of this regulation was unknown.
Similar to Hmga2, Igfbps are ‘‘oncofetal’’ genes that are highlyElsevier Inc.
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Crucial Role of HMGA2 in Myogenesisexpressed during embryonic development, usually downregu-
lated in adult tissues and reactivated in various cancers. Igf2bp2
is best known for its genetic variance linked to the risk of type 2
diabetes (Christiansen et al., 2009). However, few functional
studies of IGF2BP2 have been reported, and a potential role in
controlling cell proliferation or myogenesis has not been previ-
ously addressed.
In the current study, we sought to identify critical factors
regulating muscle stem cell activation and commitment, and
determined through both gain-of-function and loss-of-function
analyses that HMGA2 is a key regulator of myogenesis, both
in vitro and in vivo, acting via IGF2BP2.
RESULTS
Identification of Genes that Are Markers for
Proliferating Muscle Progenitors during Myogenesis
Activation of quiescent satellite cells, as measured by their
stimulation to proliferate, is a critical early event in regeneration
(Le Grand and Rudnicki, 2007). We asked whether genes that
are specifically expressed in proliferating myoblasts have
a required role in myogenesis. Genes that were expressed in
proliferating myoblasts but not in satellite cells were determined
by analyzing microarray data from both published data (Fukada
et al., 2007) and an internal expression study (Figure S1A
available online). A total of 642 individual genes whose mRNA
levels are at least 5-fold higher in proliferating myoblasts in
comparison to quiescent satellite cells were labeled as consti-
tuting a ‘‘Proliferation Signature’’ (Figure S1A). Next, microarray
data from a myoblast differentiation time course experiment
allowed for the identification of a group of 328 genes as a
‘‘Differentiation Signature’’—these were genes whose levels
decrease during muscle differentiation, dropping by more than
80% at day 5 in comparison to day 0 of differentiation (Fig-
ure S1A). By overlapping the two gene sets, 139 genes were
left that are expressed at high levels in proliferating myoblasts
but that are not expressed to an appreciable degree in satellite
cells or in day 5 differentiated myotubes (Figure S1A;
Table S1). This last group of genes constitutes a ‘‘Myoblast
Signature.’’ Consistent with their association with proliferative
status, genes in the Myoblast Signature are highly enriched for
cell cycle regulators such as Cyclin B1, Cyclin A2, and Cdc2a
(Table S1). There is also a large group of genes that are involved
in modulating cell checkpoints and maintaining genome stability
during mitosis, such as Cenpa, Brca1, Aurka, Aurkb,Mcm5, and
Rad51 (Table S1). However, many genes in the Myoblast
Signature do not have well-documented roles in muscle devel-
opment, and therefore require further study. Of those, Hmga2
was particularly striking in that its mRNA level increased most
after satellite cell activation (more than 30-fold) and rapidly
turned off during terminal differentiation.
Hmga2 Is Increased upon Proliferation of Mouse
Myoblasts but Rapidly Downregulated upon
Differentiation
To determine the reproducibility of the Hmga2 mRNA pattern
obtained from the microarray data, quantitative RT-PCR (qRT-
PCR) for Hmga2 was performed on freshly isolated satellite cells
obtained from the C57BL/6 mouse, which were then induced toDevelopmentabecome proliferating myoblasts and subsequently differentiated
into myotubes (Figures S1B and S1C). qRT-PCR further con-
firmed that cells demonstrated gene perturbations consistent
with their activation and proliferation, such as regulation of
Pax7, MyoD, and Myf5 (Figure S2A).
We then sought to use qRT-PCR to verify the microarray-
obtained pattern of Hmga2 expression during myogenesis.
By qRT-PCR, Hmga2 mRNA levels were found to strongly
increase when satellite cells were activated to proliferate,
becoming committed myoblasts (Figure 1A). When myoblasts
were induced to differentiate, the Hmga2 mRNA level then
gradually decreased (Figure 1A). These data demonstrated
that Hmga2 mRNA was positively associated with proliferative
activity of myogenic cells, and negatively correlated with
terminal differentiation.
The HMGA2 protein level was next determined. Consistent
with the high mRNA level, immunofluorescence demonstrated
that HMGA2 protein was easily visible in myoblasts, and exclu-
sively localized to the nuclei, consistent with its role as a DNA
binding protein (Figure S2B). When the mouse myoblasts were
switched to differentiation medium, HMGA2 protein level contin-
uously decreased (Figure 1B). This same pattern of HMGA2
protein was also observed in C2C12 cells, a commonly used
immortalized mouse myoblast cell line (Figure S2C).
In order to further investigate the relationship betweenHMGA2
protein expression and myoblast differentiation at the single cell
level, immunofluorescence of HMGA2 and MHC was performed
on partially differentiated primary myoblasts. While 35%-45% of
the nuclei of total cultured cells stained positive for HMGA2,
essentially all MHC positive (MHC+) terminal-differentiated
myotubes were HMGA2 negative (HMGA2) (Figure 1C). There-
fore, HMGA2 and MHC expression are mutually exclusive.
Thus, Hmga2 mRNA and protein levels are upregulated in
proliferating myoblasts and subsequently become downregu-
lated coincident with differentiation.
HMGA2 Is Expressed in Neonatal and Regenerating
Muscle but Not in Mature Muscle In Vivo
After observing that HMGA2 is specifically expressed in cultured
proliferating myoblasts in vitro, it was of interest to analyze the
relative levels of HMGA2 protein in skeletal muscle cells in vivo.
Neonatal muscle and regenerating muscle were examined,
because these two sources contain proliferating muscle progen-
itor cells (myoblasts). Adult skeletal muscle, which has very low
myogenic activity and therefore lacks appreciable numbers of
activated myoblasts, was also analyzed as a control.
By western blot, HMGA2 protein was detected in neonatal but
not adult skeletal muscles (Figure 1D). Double immunofluores-
cence of HMGA2/ Pax7, or HMGA2/MyoD further revealed that
HMGA2 protein expression was coincident with Pax7 or MyoD
(Figure 1E), demonstrating that HMGA2 is highly expressed in
proliferating myoblasts in vivo.
Induction of regeneration in adult skeletal muscle, using
cardiotoxin (CTX), also makes it possible to identify populations
of proliferating and differentiating myoblasts. A time-course of
muscle regeneration was analyzed using H&E-stained sections
from muscles sampled 3, 7, and 14 days following CTX adminis-
tration (Figure S2D). As expected in this model, there was an
initial inflammatory cell infiltration at day 3 following injury. Newlyl Cell 23, 1176–1188, December 11, 2012 ª2012 Elsevier Inc. 1177
Figure 1. Hmga2 Is a Signature Gene in
Undifferentiated Myoblasts In Vitro and
In Vivo
(A) Real-time PCR verified that Hmga2 mRNA is
upregulated upon satellite cell activation, remains
upregulated during the proliferation phase, and
turns off during myoblast differentiation. Fresh
satellite cells were isolated from 8-week-old
C57BL/6 mice, as reported before. Cells were
directly sorted into TRIzol for mRNA isolation
(satellite cells) or cultured in proliferation medium
for 4 days (myoblasts) and then switched to
differentiation medium (myotube day 3 and day 7)
for another 7 days. Real-time PCR was performed
to quantify Hmga2 mRNA level. Data were
normalized to Gapdh and 18 s mRNAs. Hmga2
mRNA in quiescent satellite cell was set as 1.0.
Error bars depict mean ± SEM.
(B) HMGA2 protein levels gradually decreased
during primary myoblast differentiation. Pri-
mary myoblasts were cultured in growth medium
to reach 80% confluence and switched into
differentiation medium for up to 3 days. Nuclei
proteins were isolated and western blots were
performed using antibodies against HMGA2 and
Histone H3.
(C) HMGA2 expression is inversely correlated
with terminal muscle differentiation. Primary
myoblasts were grown to >80% confluence in
proliferation medium and switched to differ-
entiation medium for 2 days. Cells were then
fixed and stained for HMGA2 and MHC. At
this stage, 30%40% cells became terminally
differentiated, as evidenced by MHC expression
(scale bar: 50 mm). Most MHC positive cells are
negative for HMGA2 (white arrow: HMGA2+
MHC nuclei). More than 95% of nuclei of MHC
positive cells are HMGA2 negative. MHC+ nuclei
represent nuclei that are associated with cyto-
plasmic MHC expression. **p < 0.01 versus
HMGA2+ nuclei in MHC+ subset. Error bars
depict mean ± SEM.
(D) Muscle protein samples were harvested from
postnatal (1 day) or adult (12 weeks) C57BL/6
mice and western blots were performed, using antibodies against HMGA2 and a-tubulin. HMGA2 protein is detected in neonatal but not adult skeletal muscle
tissues. Neo, neonatal.
(E) Immunofluorescence demonstrates that HMGA2 is colocalized with Pax7 and MyoD in the nuclei of neonatal muscle tissues. Neonatal muscle was stained
using antibodies against HMGA2, or Pax7, or Laminin or MyoD. DAPI was used to stain nuclei. White arrow indicates Pax7/HMGA2 double-positive or MyoD/
HMGA2 double-positive cells (scale bar: 10 mm) Quantification of staining demonstrates that more than 80% Pax7+ or MyoD+ myoblasts are also HMGA2+.
(F) Immunofluorescence demonstrates that HMGA2 is colocalized with Pax7 and MyoD in the nuclei of regenerating muscle tissues. Mouse TA muscle was
treated with dry ice to induce a muscle injury, as previously reported (see Experimental Procedures), and muscle samples were harvested 5 days later. Muscle
samples were stained using antibodies against HMGA2, or Pax7, or Laminin or MyoD. DAPI was used to stain nuclei. White arrow indicates Pax7/HMGA2
double-positive or MyoD/HMGA2 double-positive cells (scale bar: 10 mm) Quantification of staining demonstrates that more than 80% Pax7+ or MyoD+
myoblasts are also HMGA2+.
See also Figure S2 and Table S1.
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Crucial Role of HMGA2 in Myogenesisformed immature myotubes with centralized nuclei were widely
observable at day 7, and the area of injury was fully regenerated
at day 14. After performing HMGA2 and Desmin double-immu-
nofluorescence staining, HMGA2 was not detected in uninjured
adult muscle. However, at day 3 following injury, many mononu-
cleated cells present in the injury site stained intensely for
HMGA2. At day 7, HMGA2 was mainly detected in the central-
ized nuclei located within newly formed myofibers. At day 14,
HMGA2 protein level further decreased but was still present in
nuclei of some regenerated myofibers (Figure S2D). Therefore,1178 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012HMGA2 is only expressed in immature myogenic cells, including
myoblasts, during regeneration.
To test whether HMGA2 is reproducibly induced during regen-
eration, as opposed to being idiosyncratically induced by cardi-
otoxin, a second, well-established model of muscle injury was
analyzed: freezing the muscle to cause an injury and thereby
induce regeneration. HMGA2 was found to be strongly induced
5 days after freezing injury (Figure 1F), detectable in centralized
nuclei. Interestingly, more than 80% of Pax7+ or MyoD+ cells
also expressed HMGA2 (Figure 1F), further demonstrating thatElsevier Inc.
Figure 2. Hmga2 Knockout Mice Demon-
strate Deficiency in Muscle Growth
(A) Comparison of female Hmga2 knockout (KO)
and wild-type (WT) mice at 8 weeks of age. As
reported previously, the Hmga2 KO mice have
a ‘‘pygmy’’ phenotype, with a body weight of
about 40% of WT littermates. *p < 0.05 Hmga2
KO mice versus WT mice. Error bars depict
mean ± SEM.
(B) Side-by-side comparison of various tissues
including skeletal muscle from Hmga2 KO andWT
mice. TA, tibialis anterior; GSP, soleus-gastroc-
nemius-plantaris complex; QUAD, quadricep. All
organs examinedwere smaller inHmga2KOmice.
(C) The weights of various tissues were normalized
to body weight. After normalization, all examined
skeletal muscle tissues fromHmga2KOmicewere
still significantly smaller than those from Hmga2
WT mice. In contrast, the brain and heart were
proportionally larger in Hmga2 KO mice, while the
relative weight of liver was almost identical in both
genotypes. Consistent with a previous report,
Hmga2 KO mice showed depletion of fat tissue,
represented by perirenal fat. *p < 0.05 Hmga2
KO mice versus WT mice. Error bars depict
mean ± SEM.
(D) Immunofluorescence of Pax7, Laminin, and
DAPI on cross-sections of Hmga2 KO and WT
mice. Hmga2 KO mice show a smaller cross-
section area (CSA) and reduced Pax7 staining.
Arrows indicate Pax7+ cells. Scale bar represents
50 mm.
(E) Comparison of CSA from Hmga2 WT and KO
mice reveal that Hmga2 KO mice have smaller
myofibers. Histogram demonstrates an enrich-
ment of small muscle fibers and lack of big fibers in
Hmga2 KO mice versus Hmga2 WT mice.
(F) Hmga2 KOmice had fewer Pax7+ cells per 500
fibers. At least 3,000 fibers were counted for each
sample. *p < 0.05 Hmga2 KO mice versus Hmga2
WT mice. Error bars depict mean ± SEM.
See also Figure S3.
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Crucial Role of HMGA2 in MyogenesisHMGA2 is expressed in immature muscle cells during early myo-
genesis in vivo.
Skeletal Muscle Is Severely Compromised in Adult
Hmga2 Knockout Mice
Next Hmga2 knockout (KO) mice were studied to determine
HMGA2’s in vivo requirement. Mice that are null for Hmga2
had been reported to demonstrate a decrease in fat tissue
(Anand and Chada, 2000), but their skeletal muscle had not
been characterized before. As shown previously, adult Hmga2
KO mice have a pygmy phenotype and are significantly smaller
than wild-type (WT) littermates. Their body weight was only
about 40%of that ofWT littermates at 8weeks of age (Figure 2A).
Comparison of KO hindlimb muscles to those from WT animals
revealed a significant decrease in relative skeletal muscle size
in Hmga2 KO mice (Figures 2B and S3A); because Hmga2 KO
mice were significantly smaller than WT littermates, we normal-
ized all the organ weights to the body weight. Interestingly, the
normalized weights of these organs demonstrated that only theDevelopmentaskeletal muscle and fat tissues were smaller out-of-proportion
to the body weight (Figure 2C). For example, after body weight
normalization, liver weight was almost identical between
Hmga2 KO and WT mice, and the heart and brain were actually
proportionally larger in Hmga2 KOs (Figure 2C) These data
suggest that HMGA2 is particularly important for skeletal muscle
growth.
To understand the nature of the hypotrophic skeletal muscle
observed in Hmga2 KO mice, skeletal muscle cross-sections
from Hmga2 KO and WT mice were stained by hematoxylin
and eosin (H&E) or immunostained with an anti-Laminin antibody
(Figures 2D and S3B); the Hmga2 KO mice had a prevalence of
smaller myofibers, demonstrated by a reduced cross-section
area (CSA), in comparison to WT littermates (Figures 2E, S3B,
and S3C). Because HMGA2 is mostly expressed in undifferenti-
ated myoblasts, the muscle stem/progenitor cell number was
counted in Hmga2 KO and WT mice by Pax7 staining. There
was a significant, 40%50%, decrease of Pax7+ cell number
in Hmga2 KO mice (Figure 2F), suggesting that the lack ofl Cell 23, 1176–1188, December 11, 2012 ª2012 Elsevier Inc. 1179
Figure 3. Hmga2 KO Mice Have Significant
Deficiency in Muscle Growth during the
Postnatal Growth Phase
(A) Postnatal skeletal muscle growth is severely
impaired in Hmga2 KO mice. Hmga2 WT and KO
mice were sacrificed at day 7, day 21, and day 42
after birth, and skeletal muscle from hindlimbs
were collected and weighed Skeletal muscle
growth in Hmga2 KO was significantly slower than
those in WT or Het littermates. *p < 0.05 Hmga2
KO mice versus Hmga2 WT mice. Error bars
depict mean ± SEM.
(B) Early skeletal muscle growth is most affected
by the loss of Hmga2. Data from (A) were
normalized to mouse body weight at different time
points. While both WT and Het mice showed
strong muscle growth between day 7 and day 21,
this growth phase was essentially abolished in
Hmga2KOmice. *p < 0.05Hmga2KOmice versus
Hmga2 WT mice. Error bars depict mean ± SEM.
(C) Hmga2 KO mice show decreased cell prolif-
eration during neonatal growth phase. TA muscle
from 7-day-old Hmga2 WT and KO mice were
harvested, fixed, and stained for antibodies as
indicated. Hmga2 KOs showed significant reduc-
tion of Ki67+ nuclei in skeletal muscle samples,
indicating impaired cell proliferation in vivo.
*p < 0.05 versus Hmga2 WT mice sample. Error
bars depict mean ± SEM.
(D) Hmga2 KO mice form smaller fibers during
regeneration. Hmga2 KO and WT mice were
injected with 10 mM CTX and samples were har-
vested 7 days and 14 days after injection. H&E
staining was performed. Both KO andWTmuscles
fully regenerated at day 14. Newly formed
myofibers, judged by their centralized nuclei, were
significantly smaller in Hmga2 KO mice. *p < 0.05
versus Hmga2 WT sample. Error bars depict
mean ± SEM.
(E) Hmga2 KO mice have weakened and delayed
regeneration. Hmga2 KO and WT mice were in-
jected with 10 mM CTX and protein samples were
harvested 3, 7, 10, and 14 days after injury. Pax7
western blots indicated that Pax7 level is higher in
WT muscle at day 3. Pax7 protein is persistent in
KO but not WT samples at day 7.
See also Figure S4.
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Crucial Role of HMGA2 in MyogenesisHMGA2 causes a decreasedmuscle progenitor pool—leading to
smaller muscle fibers.
Because the skeletal muscle phenotype had not been studied
in Hmga2 KO mice before, we decided to further characterize
these mice, by initially tracking body and muscle weights after
birth. At day 7, Hmga2 KO mice were only slightly smaller than
WT mice (Figure S4A). However, the growth of Hmga2 KO
mice was significantly impaired during the postnatal growth
phase, particularly between day 14 and 28 (Figure S4A). In addi-
tion to body weight, skeletal muscle weights were only modestly
lower at day 7, but then were increasingly retarded in growth
between day 7 and 42 (Figure 3A). The skeletal muscle growth
index, a number generated by normalizing skeletal muscle
weight to whole animal body weight, was calculated at days 7,
21, and 42 (Figure 3B). In contrast to the WT animals, which
demonstrated the expected increase in muscle growth, Hmga2
KO mice experienced an almost flat skeletal muscle growth1180 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012index throughout the growth period (Figure 3B). The significant
deficiency in skeletal muscle growth between day 7 and 21 in
KOs suggests that HMGA2 is particularly crucial for early post-
natal skeletal muscle growth, consistent with a role in muscle
satellite cell activation and proliferation.
To directly examine cell proliferation, immunofluorescence of
cell proliferation marker Ki67 on neonatal muscle samples from
Hmga2 KO and WT mice was performed. Samples from
Hmga2 KO mice demonstrated a significant, 50%60%, re-
duction in the number of Ki67+ cells in comparison toWT control
(Figure 3C). No significant apoptosis signal was detected in
either Hmga2 KO or WT samples by cleaved PARP antibody or
TUNEL assays in vivo (data not shown). These data indicate
that reduced cell proliferation in Hmga2 KO mice could
contribute to the defect in muscle growth.
Reduced myoblast proliferation may have consequence not
only on neonatal muscle growth but also muscle regeneration;Elsevier Inc.
Figure 4. Hmga2 KO Myoblasts Demon-
strated Reduced Cell Proliferation and
Self-Renewal
(A) Myoblasts from Hmga2 KO mice show
decreased cell proliferation. Myoblasts were iso-
lated fromHmga2WTandKOmice. A total of 2,000
myoblasts were seeded into each well of 96-well
plates. Pictures were taken 7 days after seeding.
(B) Myoblasts from Hmga2 KO mice grow slower
than those fromWT. Myoblasts were isolated from
Hmga2 WT and KO mice. A total of 10,000
myoblasts were seeded into each well of 24-well
plates. Cell numbers were counted at day 1, day
3, and day 7 after seeding. *p < 0.05 versus
Hmga2 WT sample at the same time point. Error
bars depict mean ± SEM.
(C) Hmga2 KO myoblasts have decreased BrdU
incorporation in proliferation medium. A total of
5,000 myoblasts from Hmga2 KO and WT mice
were seeded into each well of 96-well plates.
BrdU assays were performed by BrdU Cell
Proliferation Assay Kit (Cell Signaling Technology)
according to the manufacturer’s guidance. *p <
0.05 versus Hmga2 WT sample. Error bars depict
mean ± SEM.
(D) Hmga2 KO myofibers are smaller and contain
fewer satellite cells. Fresh isolated single fibers
from WT and KO mice were fixed and stained for
Pax7 to label satellite cells. ***p < 0.01 versus
Hmga2WTsample. Error bars depictmean±SEM.
(E) Hmga KO fibers have decreased number of asymmetric satellite cell divisions. Hmga2 KO and WT myofibers were cultured for 2 days to allow satellite cell
activation. Fibers were fixed and stained for Pax7 andMyoD. A small percentage of WT satellite cells was dividing asymmetrically. No asymmetric divisions were
observed in Hmga2 KO myofibers. ***p < 0.01, *p < 0.05 versus Hmga2 WT sample. Error bars depict mean ± SEM.
See also Figure S5.
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Crucial Role of HMGA2 in Myogenesiswe therefore compared Hmga2 KO and WT mice after CTX
induced muscle regeneration. At day 7 and day 14 after
injury, the regenerating fibers were much smaller in Hmga2
KO mice, with an average 50% reduction in CSA (Figure 3D).
Other than that, Hmga2 WT and KO samples showed similar
morphology in general, such as the presence of centralized
nuclei and a similar degree of inflammation at day 7, and
almost complete regeneration at day 14 (Figure 3D). To further
compare the differences of WT and Hmga2 KO muscles during
regeneration, protein samples were harvested and western
blots were performed. In comparison to WT, KO muscle
samples showed much weaker Pax7 activation at day 3, con-
sistent with fewer satellite cells/muscle fibers in KO mice.
Interestingly, at day 7, while Pax7 levels had significantly
decreased in WT muscle, Pax7 levels remained high in
KO muscles. Therefore, regeneration can be completed in
Hmga2 KO muscle, but the process was delayed and resulted
in smaller muscles.
Muscle atrophy inWTmyofibers can be induced by a variety of
cachectic stimuli, resulting in part from protein degradation
caused by induction of the E3 ubiquitin ligases MuRF1 and
MAFbx (Bodine et al., 2001). To determine whether the decrease
in muscle mass caused by Hmga2 loss could be partially due to
an induction in muscle atrophy pathways, mRNA levels of
MuRF1 and MAFbx were determined; neither were significantly
changed (Figure S4B), demonstrating that HMGA2 does not
affect these atrophy pathways.DevelopmentaHMGA2 Affects Myoblast Proliferation and Cell Fate
Decision
To directly examine whetherHmga2KO has a defect in myoblast
proliferation, we next compared the growth rate of myoblasts
isolated from Hmga2 KO and WT mice. Myoblasts were
successfully cultured for more than 20 passages. Hmga2
KO myoblasts demonstrated slower growth rates (Figures 4A
and 4B) and lower BrdU incorporation than WT controls (Fig-
ure 4C). To investigate whether HMGA2 also regulates differen-
tiation, myoblasts were grown and differentiated in vitro.
Because myoblast differentiation could be affected by cell
density, we performed differentiation experiments under both
low and high cell density. When cells were seeded at low density
and allowed to proliferate for 2 days before serum was with-
drawn, the number of myotubes formed with multiple nuclei
was significantly reduced in cells obtained from the Hmga2 KO
mice (Figure S5A). However, when myoblasts were seeded at
high density and induced to differentiate without proliferation,
no difference was observed. Both WT and KO myoblasts differ-
entiated well and were stained strongly by MHC (Figure S5B).
Therefore, HMGA2 is not required for myoblast terminal differen-
tiation, but it does perturb proliferation, and thus differentiation
is affected when cell numbers are limiting.
Genes regulating myoblast proliferation may also play roles in
cell fate decisions. To examine whether HMGA2 has a role in this
process, we isolated single fibers from both Hmga2WT and KO
muscles. Consistent with previous findings, KO fibers werel Cell 23, 1176–1188, December 11, 2012 ª2012 Elsevier Inc. 1181
Figure 5. HMGA2 Regulates IGF2BP2 in
Myoblasts
(A) Igf2bp2 is one of the top genes regulated by
HMGA2 in myoblasts. ‘‘Volcano Plot’’ of micro-
array data showing expression profiles of Hmga2
KO and WT myoblasts. Igf2bp2 is one of the most
significantly downregulated genes in Hmga2 KO
myoblasts.
(B) Microarray data show that Igf2bp2 is down-
regulated in Hmga2 KO myoblasts. Myoblasts
isolated from four WT and five KO mice were used
for microarray analysis.
(C) Hmga2 and Igf2bp2 have similar expres-
sion patterns during myogenesis. mRNAs were
harvested from freshly isolated satellite cells,
myoblasts, immature myotubes (day 3 differenti-
ation), and mature muscle samples. RT-PCR
assays were performed to examine the expression
of Hmga2 and Igf2bp2 mRNA levels. Data were
normalized to Gapdh and 18 s mRNAs. Error bars
depict mean ± SEM.
(D) Igf2bp2mRNA is downregulated in Hmga2 KO
myoblasts. mRNA samples were harvested from
two Hmga2 KO and two Hmga2 WT myoblasts.
RT-PCRs were performed to examine Igf2bp2
level. Data were normalized to Gapdh and 18 s
mRNAs. Error bars depict mean ± SEM.
(E) IGF2BP2 protein is downregulated in
Hmga2 KO myoblasts. Protein samples were
harvested from two Hmga2 KO and two plates
of Hmga2 WT myoblasts. Western blots were
performed using antibodies against HMGA2,
IGF2BP2, and Histone H3.
(F) Overexpression of HMGA2 in myoblasts
increases Igf2bp2 mRNA levels. Lentiviral con-
structs expressing HMGA2 or empty control were
used to infect myoblasts, and 72 hr after infection,
mRNAs were harvested and RT-PCRs were per-
formed to examine mRNA levels of Hmga2 and
Igf2bp2. Data were normalized to Gapdh and
18 s mRNAs. *p < 0.05 HMGA2 overexpression
versus vector control sample. Error bars depict
mean ± SEM.
(G) Exogenous expression of HMGA2 inmyoblasts
increases IGF2BP2 protein. Lentiviral constructs
expressing HMGA2 or empty control were used to
infect myoblasts. 72 hr after infection, protein
samples were harvested and western blots were performed using antibodies against HMGA2, IGF2BP2, and Histone H3.
(H) HMGA2 protein directly binds to Igf2bp2 first intron region. Myoblast cells were fixed and chromatin IP was performed using IgG or antibodies against HMGA2
or p65. After DNA elution, primers sets detectingGapdh promoter, IgH enhancer, and Igf2bp2 first intron sequences were used for RT-PCR analysis. HMGA2 and
p65 showed enriched binding to Igf2bp2 intron, but they were not recruited toGapdh promoter or IgH enhancer. *p < 0.05 with comparison of relative recruitment
of HMGA2 or p65 and IgG to Igf2bp2 Intron region. Error bars depict mean ± SEM.
See also Table S2.
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Crucial Role of HMGA2 in Myogenesissmaller in diameter and have significantly fewer satellite cells per
fiber (Figure 4D). After 2 days in culture, when satellite cells
undergo their first division (Rudnicki et al., 2008; Zammit et al.,
2004), most satellite cells from WT muscle appeared as
doublets, both expressing Pax7+/MyoD+, consistent with
symmetric divisions. A small percentage of satellite cells divide
asymmetrically, with one cell retainingMyoD and the other losing
MyoD, indicating that a fraction of satellite cells reacquire a
self-renewing fate (Olguin and Olwin, 2004; Zammit et al.,
2004). By contrast, all Hmga2 KO satellite cells were MyoD+
and therefore had divided symmetrically (Figure 4E). In conclu-
sion, losing HMGA2 not only decreased myoblast growth, but1182 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012also reduced the self-renewal potential of satellite cells. These
data help explain the reduced number of satellite cells and
smaller fibers observed in Hmga2 KO mice.
IGF2BP2 Is a Top HMGA2 Target in Myoblasts
It was next important to investigate the mechanism by which
HMGA2 controls myoblast proliferation and early myogenesis.
mRNAs were isolated from Hmga2 KO and WT myoblasts, and
a microarray was performed. A total of 28 genes were found to
be significantly downregulated and 30 genes were significantly
upregulated in Hmga2 KO myoblasts in comparison to WT
samples (fold change > 2, p < 0.001) (Figure 5A; Table S2).Elsevier Inc.
Figure 6. IGF2BP2 Is Important for
Myoblast Growth and Could Partially
Rescue the Growth Deficiency of Hmga2
KO Myoblasts
(A) Successful knockdown of IGF2BP2 using
siRNAs in myoblasts. Two individual siRNAs
against IGF2BP2 and one nontargeting (NT)
control siRNA were transfected into myoblasts,
and protein samples were harvested 3 days after
transfection. Western blots were performed using
antibodies against IGF2BP2 and Histone H3.
(B) Knockdown of IGF2BP2 in myoblasts
decreases cell growth. A total of 200,000
myoblasts were seeded into each well of 6-well
plates. Cells were transfected with NT or Igf2bp2
siRNAs. Pictures were taken 5 days after trans-
fection.
(C) Knockdown of IGF2BP2 in myoblasts
decreases cell growth. A total of 10,000 myoblasts
were seeded into each well of 96-well plates. Cells
were transfected with NT or Igf2bp2 siRNAs at day
0. Cell titers were measured at day 0, 1, 3, 5, and 7
after transfection by CellTiter-Glo Luminescent
Cell Viability Assay kit (Promega). *p < 0.05 versus
si-NT samples at the same time point. Error bars
depict mean ± SEM.
(D) Knockdown of IGF2BP2 in myoblasts
decreases BrdU incorporation. Myoblasts were
seeded into each well of 96-well plates. Cells were
transfected with NT or Igf2bp2 siRNAs at day 0. At
day 5, BrdU assays were performed by BrdU Cell
Proliferation Assay Kit (Cell Signaling Technology),
according to the manufacturer’s guidance.
*p < 0.05 versus si-NT samples. Error bars depict
mean ± SEM.
(E) Overexpression of IGF2BP2 in Hmga2 KO
myoblasts. Lentivirus expressing IGF2BP2 were
infected intoHmga2KOmyoblasts. Three days after infection, protein samples were harvested.Western blots were performed using antibodies against IGF2BP2
and Histone H3.
(F) Overexpression of IGF2BP2 could partially rescue the proliferation deficiency of Hmga2 KO myoblasts. A total of 5,000 Hmga2 KO and WT myoblasts were
seeded into each well of 96-well plates. Lentivirus expressing IGF2BP2 or HMGA2 was used to infect cells. BrdU assays were performed 5 days after infection.
*p < 0.05. Error bars depict mean ± SEM.
Developmental Cell
Crucial Role of HMGA2 in MyogenesisSurprisingly, p16Ink4A and p19ARF, reported targets of HGMA2 in
neural stem cells (Nishino et al., 2008), were not regulated by
HMGA2 in myoblasts. Of all the downregulated genes, Igf2bp2
is particularly interesting. First, it is the most significantly down-
regulated gene in Hmga2 KO myoblasts, and two independent
probes against Igf2bp2 were identified among the top 5 regu-
lated genes (Figures 5A and 5B). Second, Igf2bp2 has a very
similar expression pattern as Hmga2 during myogenesis: low in
quiescent satellite cells, strongly upregulated in myoblasts,
and gradually downregulated during terminal differentiation
(Figure 5C). These data strongly suggest HMGA2 may regulate
Igf2bp2 expression in myoblasts. qRT-PCR confirmed that
Igf2bp2 mRNA was significantly downregulated in Hmga2 KO
myoblasts (Figure 5D). Western blots demonstrated that
IGF2BP2 protein was almost undetectable in Hmga2 KO
myoblasts (Figure 5E). Moreover, when HMGA2 was overex-
pressed in myoblasts, using a lentiviral construct, both Igf2bp2
mRNA and protein levels increased (Figures 5F and 5G). All these
data demonstrate that Igf2bp2 is a downstream target for
HMGA2 in myoblasts, and that HMGA2 is required for Igf2bp2
protein to be made.DevelopmentaIGF2BP2 was previously reported to be potentially regulated
by HMGA2 during embryonic development (Cleynen et al.,
2007), although the biological significance of this regulation re-
mained unclear. HMGA2 was shown to bind to the first intron
of Igf2bp2, where it enhanced the binding of NF-kB factors
such as p65 and p50 (Cleynen et al., 2007). To investigate
whether this mechanism is conserved in myoblasts, chromatin
immunoprecipitation was performed, and direct binding of
HMGA2 and p65 to the Igf2bp2 intron region was detected. By
contrast, HMGA2 and p65 don’t bind to either Gapdh promoter
or IgH enhancer regions (Figure 5H).
IGF2BP2 Regulates Myoblast Proliferation, and
Overexpressing IGF2BP2 Can Partially Rescue the
Growth Deficiency of Hmga2 KO Myoblasts
The roles of IGF2BP2 in myogenesis or cell proliferation in
general have not been studied. Therefore, we investigated
whether the regulation of IGF2BP2 by HMGA2 is biologically
relevant. siRNAs against Igf2bp2 were used to knock down
IGF2BP2 protein and they successfully reduced IGF2BP2
protein by 70%80% (Figure 6A). Two independent Igf2bp2l Cell 23, 1176–1188, December 11, 2012 ª2012 Elsevier Inc. 1183
Developmental Cell
Crucial Role of HMGA2 in MyogenesissiRNAs significantly decreased myoblast growth as measured
by CellTiter assay (Figures 6B and 6C). They also caused
a decrease in BrdU incorporation (Figure 6D), proving that
a decline in IGF2BP2 reduced cell proliferation.
These data point to the possibility that the HMGA2 effect on
myoblast proliferation could be at least partially mediated by
IGF2BP2. To examine this, IGF2BP2 was overexpressed in
Hmga2 KO myoblasts. Western blots confirmed that IGF2BP2
overexpression restored the protein level, comparable to that
in Hmga2 WT myoblasts (Figure 6E). Importantly, overexpres-
sion of either HMGA2 itself or IGF2BP2 significantly increased
the proliferation of Hmga2 KO myoblasts (Figure 6F).
Taken together, these data indicate that IGF2BP2 is a func-
tional target for HMGA2 in myoblasts, and that add-back of
IGF2BP2 can largely rescue the HMGA2 null effect on myoblast
proliferation.
IGF2BP2 Regulates the Protein Production of Multiple
Genes Important for Cell Growth
We next investigated the molecular mechanism by which
IGF2BP2 regulates myoblast growth. After binding to mRNAs,
IGF2BPs reportedly can either positively or negatively regulate
their translation (Christiansen et al., 2009). For example,
IGF2BP2 could bind to Igf2 mRNA and enhance its translation
(Dai et al., 2011). We therefore asked whether IGF2BP2 controls
myoblast proliferation by regulating the translating ofmRNAs. By
analyzing a public database (Hafner et al., 2010), exogenously
overexpressed IGF2BP2 was found to bind to as many as
2,184 different mRNAs in 293 cells. Interestingly, the top 100
IGF2BP2 binding mRNAs are highly enriched in genes important
for cell growth, including c-myc, Sp1, and Igf1r (Table S3). To
examine whether endogenous IGF2BP2 also binds to these
mRNAs in primary mouse myoblasts, RNA-binding protein
immunoprecipitation was performed to pull down IGF2BP2
protein from a myoblast lysate, and the binding RNAs were
determined. Many of the reported mRNAs were confirmed to
be bound by endogenous IGF2BP2, including c-myc, Sp1,
Igf1r, Cyclin G1, Notch 2, Cdk6, Akt 3, Mdm2, Ki67, Arf1, and
Mapk1. By contrast, Gapdh, Hdac1, and Smurf mRNAs did not
significantly bind to IGF2BP2 in myoblasts. Surprisingly,
no strong binding of Igf2 mRNA to IGF2BP2 was observed
(Figure 7A).
To investigate whether IGF2BP2 could affect the translation of
the determined target mRNAs, IGF2BP2 was knocked down by
siRNA in myoblasts. Three days after transfection, western blots
were performed to examine protein levels of the candidates
determined by pull down. Protein levels of c-Myc, SP1 and
IGF1R were significantly reduced upon IGF2BP2 siRNA treat-
ment (Figure 7B). Interestingly, IGF2BP2 siRNA did not signifi-
cantly change levels of c-myc,Sp1, and Igf1rmRNAs (Figure 7C),
suggesting that IGF2BP2 knockdown could perturb protein
levels of target mRNAs in myoblasts without affecting overall
mRNA levels.
Because Hmga2 KO myoblasts have significantly less
IGF2BP2, the protein levels of IGF2BP2-required targets should
also decrease in Hmga2 KO myoblasts. Indeed, Hmga2 KO
myoblasts showed a significant reduction of c-Myc, SP1, and
IGF1R proteins (Figure 7D). Similar to the previous Igf2bp2
siRNA experiments, c-myc, Sp1, and Igf1r mRNAs were not1184 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012differentially expressed between Hmga2 KO and WT myoblasts
(Figure S6A). To directly assess whether mRNA translation is
reduced in Hmga2 KO myoblasts, polysome isolation experi-
ments were performed (Figure S6B). Percentages of c-myc,
Sp1, and Igf1r mRNAs associated with polysomes were all
reduced in Hmga2 KO myoblasts (Figure 7E), proving that their
translation was inhibited. Because c-Myc, SP1, IGF1R, and
many other targets all have well-known roles in cell growth and
myogenesis, the downregulation of those proteins provide ob-
vious potential explanations for the growth deficiency observed
in Hmga2 KO and Igf2bp2 siRNA-treated myoblasts.
HMGA2 in Dystrophic and Aged Muscle
To investigate whether HMGA2 is perturbed in settings of
Duchenne’s muscular dystrophy or in sarcopenia (age-
associated muscle atrophy and weakness), we first examined
the levels of Hmga2 in Mdx mice, a model for Duchenne’s.
mRNA samples were harvested from young (week 4), diseased
(week 10), and old (week 50) Mdx and control mice. At various
disease stages, Hmga2 mRNA levels were all higher in Mdx
muscles in comparison toWT controls (Figure 8A). This is consis-
tent with the continuous cycle of degeneration/regeneration and
myoblast proliferation in dystrophic muscles (Bulfield et al.,
1984; Tanabe et al., 1986). This finding also suggests that simply
increasing HMGA2 levels is unlikely to ameliorate the phenotype
seen in this type of muscle dystrophy, because HMGA2 is
already upregulated.
Aged muscle reportedly is coincident with a significant reduc-
tion in stem cell function (Brack and Rando, 2007; Day et al.,
2010). To examine whether HMGA2 is involved in the sarcopenic
phenotype, mRNAs were compared using a collection of human
myoblasts of different ages. Hmga2 mRNA levels were com-
parable in young and aged myoblasts (Figure 8B). However,
differences were seen when the myoblasts were subject
to differentiation; myoblasts from 20-year-old, 50-year-old,
73-year-old, and 83-year-old donors were grown to confluence
and switched to differentiation conditions. While all samples
had similar Hmga2 levels before differentiation, the myoblasts
from the oldest population, 83 years, where sarcopenia is often
evident, did not show a statistically significant difference
between undifferentiated and differentiated levels of Hmga2, in
contrast to the other age groups (Figure 8C); this is consistent
with the finding that these myoblasts demonstrate delays and
an overall deficiency inmyoblast differentiation (data not shown).
Interestingly, reduction of HMGA2 seems crucial for differen-
tiation, because constitutive overexpression of HMGA2 in
myoblasts inhibits terminal differentiation (Figure S7). Our data
together demonstrate that reduced proliferation capacity of the
most aged myoblasts is not correlated with Hmga2 levels.
However, the deficiency of shutting off Hmga2 during differenti-
ation might play a role in reduced myogenesis.
DISCUSSION
The activation and proliferation of skeletal muscle progenitor
cells is one of the first required steps for muscle development
and regeneration. The loss of the ability to regenerate muscle
is part of the pathophysiology of muscular dystrophies (Blau,
2008) and has also been implicated as contributing to theElsevier Inc.
Figure 7. IGF2BP2 Binds to a Set of mRNAs
and Regulates Protein Production
(A) IGF2BP2 binds to the mRNAs of genes
involved in cell growth control. Immunoprecipita-
tions were done using control IgG or IGF2BP2
antibodies Coimmunoprecipitated RNAs were
eluted and analyzed by RT-PCR. IGF2BP2
strongly binds to the mRNAs of c-Myc, Sp1, Igf1r
and several others, but not Gapdh, Igf2, Hdac1,
and Smurf mRNAs. *p < 0.05 versus IgG control.
Error bars depict mean ± SEM.
(B) Knockdown of IGF2BP2 decreases protein
levels of c-Myc, SP1, and IGF1R. Myoblasts were
transfected by Igf2bp2 siRNAs for 4 days. Protein
samples were harvested and western blots were
performed using antibodies against IGF2BP2,
c-Myc, SP1, IGF1R, and Histone H3.
(C) Knockdown of IGF2BP2 does not change the
levels of top binding mRNAs. Myoblasts were
transfected by IGF2BP2 or NT control siRNAs for
3 days. RT-PCR assays were performed using
indicating primers. Data were normalized to
Gapdh and 18 s mRNAs. *p < 0.05 versus si-NT
control. Error bars depict mean ± SEM.
(D) Hmga2 KO myoblasts have decreased c-Myc,
SP1 and IGF1R protein levels. Two WT and
two KO myoblasts were cultured in proliferation
medium. Protein samples were harvested and
western blots were performed using antibodies
against IGF2BP2, c-Myc, SP1, IGF1R, and
Histone H3.
(E) Selective mRNAs associated with polysomes
decrease in Hmga2 KO myoblasts. Polysomes
were isolated from Hmga2 KO and WT myoblasts.
Polysome mRNAs and total mRNAs were reverse
transcribed and RT-PCR assays were performed
using indicating primers. Data were normalized to
Gapdh and 18 s mRNAs. *p < 0.05 versus WT
controls. Error bars depict mean ± SEM.
See also Figure S6 and Table S3.
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Crucial Role of HMGA2 in Myogenesisloss of muscle mass associated with aging, termed sarcopenia
(Brack and Rando, 2007; Conboy et al., 2005; Ru¨egg and
Glass, 2011; Tanaka et al., 2009). Therefore, it is important to
understand the molecular mechanisms controlling the early
steps of myogenesis; toward this goal, we identified a group
of genes that are highly and specifically expressed in prolifer-
ating myoblasts during muscle regeneration. Using both gain-
of-function and loss-of-function assays, we identified HMGA2
to be a crucial regulator for muscle stem cell activation and
myogenesis.
Pronounced loss of muscle mass and smaller muscle fibers in
Hmga2 KOmice demonstrates a critical requirement for HMGA2
in postnatal skeletal muscle development in vivo. Strong evi-
dence is presented to show that reduced muscle progenitor
activity leads to small muscle fibers in Hmga2 KO mice. In
contrast to skeletal muscle, other organs—including the heart
and brain—are actually proportionally larger in Hmga2 KO
mice. This is noteworthy, because HMGA2 was previously re-Developmental Cell 23, 1176–1188, Deported to be a crucial factor for heart
development and neural stem cell self-
renewal (Monzen et al., 2008; Nishinoet al., 2008). The data also demonstrate that HMGA2 has nonre-
dundant and unique roles compared to HMGA1 in skeletal
muscle myoblasts. While Hmga2 KO mice have a loss-of-skel-
etal muscle phenotype, Hmga1 KO mice have normal body
weight, as well as regular development of most major organs
and tissues (Fedele et al., 2006).
Unlike what is reported in neural stem cells, HMGA2 does not
seem to regulate p16Ink4A or p19ARF inmyoblasts, which led us to
seek other functional downstream factors. Through an unbiased
microarray analysis, we identified IGF2BP2 as a key target and
mediator for HMGA2’s function in controlling myoblast prolifera-
tion. Although the regulation of IGF2BP2 by HMGA2 was re-
ported in another cell system (Cleynen et al., 2007), the current
study demonstrates that IGF2BP2 is crucial for cell proliferation
and myogenesis, and that it mediates a large part of the HMGA2
effect on these muscle phenotypes.
IGF2BP2 acts by binding to and promoting the translation of
various mRNAs. This function helps explain why HMGA2 andcember 11, 2012 ª2012 Elsevier Inc. 1185
Figure 8. HMGA2 Is Dysregulated in Dystrophic and Aged Muscles
(A) Hmga2mRNA levels are higher in muscle samples isolated from Mdx mice
thanWT controls. RT-PCR assays were performed usingHmga2 primers. Data
were normalized to Gapdh and 18 s mRNAs. *p < 0.05. Error bars depict
mean ± SEM.
(B) Hmga2 mRNA levels are similar in myoblasts of different ages. mRNAs
were harvested from human myoblasts with different-aged donors. RT-PCR
assays were performed usingHmga2 primers. Data were normalized toGapdh
and 18 s mRNAs. Error bars depict mean ± SEM.
(C) Impaired HMGA2 downregulation during differentiation in aged myoblasts.
mRNA levels of HMGA2 were examined in human myoblasts isolated from
different-aged donors (fetal to 83 years old). While there was no significant
difference at day 0, a clear loss of HMGA2 downregulation during differenti-
ation was observed only in cells from 83-year-old donors, where sarcopenia
was most prevalent. *p < 0.05. Error bars depict mean ± SEM.
See also Figure S7.
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Crucial Role of HMGA2 in MyogenesisIGF2BP2 are highly expressed in proliferating myoblasts, where
transcription and translation are much more active than in
quiescent stem cell or postmitotic myofibers. Given the large
number of DNA binding sites for HMGA2, it is surprising that
a single perturbed gene, in this case IGF2BP2, is responsible
for much of the phenotype seen, but that seems to be the case1186 Developmental Cell 23, 1176–1188, December 11, 2012 ª2012here. IGF2BP2 in turn binds many mRNAs, and we could at least
confirm that the three target genes—c-myc, Sp1, and Igf1r—are
all perturbed at the protein level. It will be of interest to investigate
whether other mRNA targets were also affected in a similar
manner.
The IGF1 pathway is well-established for its role in myoblast
proliferation. IGF1 stimulates myoblasts to proliferate, but also
has a biphasic role given its ability to stimulate differentiation
(Florini et al., 1986; Quinn and Roh, 1993; Engert et al., 1996;
Quinn et al., 1994). Igf1 null animals are runted, as are Igf1r null
animals (Liu et al., 1993), similar to the pygmy phenotype seen
in the Hmga2 nulls. Although c-myc is similar to IGF1 in that it
can stimulate myoblast proliferation, c-myc has an opposite
effect of IGF1 on differentiation: c-myc’s continued expression
blocks differentiation (Miner and Wold, 1991) (La Rocca et al.,
1994); thus, there is a requirement to downregulate c-myc late
in myogenesis, which is what occurs with the downregulation
of the HMGA2-IGF2BP2 axis. SP1 broadly interacts with other
transcriptional factors or epigenetic regulators and has very
important roles in early development and in cancer formation
(Black et al., 2001). As for its role in myoblast proliferation, SP1
is least studied. One important myoblast proliferation-regulating
protein that requires its SP1 binding elements to be expressed is
the FGF receptor FGFR1 (Patel and DiMario, 2001). It will be of
interest to further study FGF signaling perturbations in the
Hmga2 nulls, or the IGF2BP2 knockdown myoblasts.
In summary, the data presented here demonstrate that
HMGA2 and IGF2BP2 are critical for myoblast proliferation and
early myogenesis. When satellite cells are activated and enter
the cell cycle, HMGA2 is upregulated and directly activates the
transcription of Igf2bp2, which in turn positively controls the
protein production of multiple proliferation related genes
including c-myc, Sp1, and Igf1r. Not only is it necessary to upre-
gulate HMGA2/IGF2BP2 for optimal proliferation, but it is also
apparently required to downregulate HMGA2/IGF2BP2/c-Myc
in order for myoblasts to be able to then differentiate into multi-
nucleated skeletal muscle.
EXPERIMENTAL PROCEDURES
Animals
All procedures were performed in accordance with the standards of the US
Department of Health and Human Services and were approved by the Novartis
Animal Care and Use Committee. C57BL/6 mice and Hmga2 +/ heterozy-
gous mice (stock #002644) were obtained from Jackson Laboratories at
46 weeks of age. Mice were housed and bred at Novartis Cambridge Lab
Animal Services.
Muscle Regeneration
Muscle degeneration/regeneration by CTX was done as previously described
(Palacios et al., 2010; Sherwood et al., 2004). In brief, left TA muscles of
anesthetized 8- to 12-week-old C57BL/6 WT or Hmga2 KO mice were intra-
muscularly injected with 100 ml of 10 mM CTX. Right TA muscles of the same
mice were injected with PBS as control. Muscle samples were harvested for
immunohistochemistry at day 0, day 3, day 7, and day 14 after injection and
stained by H&E and specific antibodies. Regeneration is clearly activated in
the first 3 days and recovered by 14 days after injury.
The muscle injury induction by frozen injury was performed according to
previously described procedure (Warren et al., 2002). In brief, a small incision
was made through aseptically prepared skin overlying the left TA muscle.
Injury was induced by applying a steel probe cooled to the temperature of
dry ice to the TA muscle for 10 s. Following injury, the skin incision wasElsevier Inc.
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Crucial Role of HMGA2 in Myogenesisclosed using silk suture and treated with hydrogen peroxide. Muscle samples
were harvested at day 5 after injury and we observed amixture of regenerating
and matured muscle fibers at this time point.
Single Fiber Cultures and Immunofluorescence
For single fiber cultures, EDL muscle was digested in 0.2% Collagenase type I
(Invitrogen) in DMEM at 37C and single fibers were gently triturated. Then,
single fibers were carefully transferred into 10 ml of 5% horse serum (HS) in
DMEM (Dulbecco’s modified Eagle medium, GIBCO) and incubated at 37C
in 5% CO2 for 15 min. This was repeated a minimum of three times to remove
all bad and contracted fibers. Single fibers were then cultured in plating
medium (10% HS, 0.5% chick embryo extract [CEE; US Biological, Swamp-
scott, MA] in DMEM) for 1 day and then switched to proliferating medium
(20% fetal bovine serum [Mediatech, Herndon, VA], 10% HS, 2% CEE in
DMEM). Single fibers were fixed in 4% paraformaldehyde (PFA) for 10 min at
room temperature, permeabilized (0.2% PBS/0.2% Triton X-100 [PBST]) and
incubated in blocking solution (BS; 10%goat serum, PBST) for 30min. Primary
antibodies were incubated in BS overnight at 4C. The day after single fibers
were washed with PBST, incubated in BS for 30 min and in secondary
antibodies and DAPI to visualize nuclei for 1 hr at room temperature. After
several washes with PBST, single fibers were mounted and observed at fluo-
rescence microscopy. Antibodies used were mouse anti-Pax7 (1/100, DSHB),
rabbit anti-MyoD (1/70, Santa Cruz), and rabbit anti-Myogenin (1/200, Santa
Cruz).
Myoblast Culture and Differentiation
Primary mouse satellite cells were isolated from C57BL/6 mice. Once isolated,
satellite cells become activated and acquire myoblast property. To grow
primary myoblast, cells were cultured in F10 (GIBCO) + 20% horse serum
(GIBCO) + 2.5 ng/ml bFGF (Invitrogen) + 1% penicillin/streptomycin + 1%
Gluta-Max (GIBCO). Human myoblast cells HSMM were obtained from Lonza
(#CC-2580) and cultured with Clonetics Skeletal Muscle Myoblast Cell System
(#CC-3245 and #CC-5034) for proliferation. When induced for differentiation,
all three types of myoblast were switched from their perspective growth
medium into fusionmedium (DMEM/F12 supplemented with 2% horse serum).
When induced for differentiation, myoblasts were switched to differentiation
medium (DMEM supplemented with 5% horse serum).
Immunofluorescence and Immunohistochemistry
Staining of frozen muscle sections (8 mm thick) was performed as previously
described (Sherwood et al., 2004). Briefly, H&E staining was done by standard
protocol. For immunofluorescence, frozen sections or cells grown in chamber
slides were fixed in 4% PFA for 15min in room temperature and permeabilized
by 0.5% Triton X-100. Samples were then stained with primary antibody for
2 hr and with secondary antibody for 30 min at room temperature. Nuclei
were labeled with DAPI. Primary antibodies used are HMGA2 (Cell Signaling
#5269), MHC (Millipore, #05-833), Desmin (Cell Signaling #4024), Laminin
(Abcam, #ab11576), and Pax7 (DSHB and a gift of Chen-Ming Fan). The
secondary antibodies used are all from Invitrogen.
RNA-Binding Protein Immunoprecipitation
RNA-binding protein immunoprecipitation (RIP) was performed using Magna
RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore). Briefly, primary
mouse myoblasts were harvested by adding RIP lysis buffer. Clear superna-
tant containing IGF2BP2 protein, IgA beads, and IGF2BP2 antibody (or IgG
control) were mixed to perform immunoprecipitation. After washing, RNAs
binding to IGF2BP2 were eluted and quantified. Reverse transcription and
RT-PCRwere performed to examine whether certain mRNAs were coimmuno-
precipitated with IGF2BP2 antibody.
Signature Analysis
Proliferation Signature is analyzed and modified from published data (Fukada
et al., 2007). A total of 642 genes were identified to be upregulated more than 5
times at mRNA level in myoblast in comparison to quiescent satellite cells (see
Table S1 for full gene list). Differentiation Signature is reanalyzed and modified
from data previously published by Novartis (Gene Expression Omnibus [GEO]
number GSE11415). A total of 328 genes show steady decrease during myo-
differentiation and dropped by more than 80% at day 5.DevelopmentaStatistical Analyses
Descriptive statistics were generated for all quantitative data with presentation
of means and standard errors. Results were assessed for statistical signifi-
cance using Student’s t test (Microsoft Excel) or ANOVA analysis using the
SAS Enterprise Guide 3.0 or SigmaPlot 11.0 software.
ACCESSION NUMBERS
The GEO database accession number for the microarray reported in this paper
is GSE41907.
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